Cargando…
Breaking the Code of Amyloid-β Oligomers
Departing from the original postulates that defined various neurodegenerative disorders, accumulating evidence supports a major role for soluble forms of amyloid proteins as initiator toxins in Alzheimer's disease, Parkinson's disease, frontotemporal dementias, and prion diseases. Soluble...
Autor principal: | Lesné, Sylvain E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773433/ https://www.ncbi.nlm.nih.gov/pubmed/24072999 http://dx.doi.org/10.1155/2013/950783 |
Ejemplares similares
-
The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012) -
The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020) -
Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013) -
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016) -
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
por: Cline, Erika N., et al.
Publicado: (2018)